The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 4.6% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 59% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 150%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (5 analysts) rates it buy, with a mean price target of $241.
At the last full screen
2026-09-10
Screened 2026-09-10 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its distribution label.
EnerSys holds its Distribution at $179.02. Consolidating, no directional conviction, held for 32 days.
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 32 days |
| Price at the screen | $179.02 |
| Valuation | 19.19 trailing · 12.60 forward price to earnings |
| Values screen | PASS |
| Beta | 1.22 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 14.26% | Below 33% | Interest-bearing debt is just 14.3% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 5.44% | Below 33% | Cash held in interest-bearing accounts and securities is 5.4% of assets, under the one-third limit. | Pass |
| Receivables | 0.00% | Below 49% | Money owed to the company is 0.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades at roughly a 53% discount to our $274.55 fair value, moderate competitive moat, 4.80% revenue growth.
Fair value range in USD, drawn from the 2026-09-10 screen. The gold marker is the market price at the same screen. A 53.4% margin of safety to the base estimate.
Third-party analyst targets: 5 covering, consensus None. The average target sits +48% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-10 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsBattery Maker Looks Cheap But Growth Has Flatlined
Picture a warehouse forklift or a data centre backup system. EnerSys supplies the batteries that keep those running day after day. Yet the business is expanding revenue by just 1 percent a year while posting an 8 percent profit margin and 15 percent return on equity. At 14.6 times forward earnings the shares trade well below our calculated fair value, yet we still pass.
The moderate moat and ethical screen clearance are not enough to offset the lack of momentum. Five analysts see little upside from here and the stock offers no compelling reason to own it when faster-growing industrials exist elsewhere.
Low growth in a cyclical sector often signals peak earnings rather than a bargain. Investors chasing the apparent discount risk watching multiples compress further if industrial demand softens. Analysis, not advice.
| Forward P/E | 12.6xexpensive even after accounting for its growth |
| Trailing P/E | 19.2xreasonably valued |
| EPS, trailing | 9.33 |
| EPS, forward | 14.21 |
| Revenue growth | +4.8%slow but positive growth |
| Profit margin | 9.3%thin but positive margins |
| Return on equity | 18.4%a solid return on shareholder capital |
| FCF yield | 9.52% |
| Dividend yield | 44.00% |
| Debt to equity | 0.56moderate, manageable leverage |
| Current ratio | 2.80comfortably covers its short-term bills |
| Beta | 1.22moves a little more than the market |
| Short interest, float | 0.07% |
| 52-week range | 104.72 - 244.30 |
| Moat | MODERATE |
| Market cap | $6.5B |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeENS trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 13.4% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 59% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 150%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (5 analysts) rates it buy, with a mean price target of $241.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 59% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 150%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (5 analysts) rates it buy, with a mean price target of $241.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-13 | WYNTER RUDOLPH W | Director | 199 | $32,305 | |
| 2026-04-13 | KNAUSENBERGER LAUREN | Director | 163 | $26,467 | |
| 2026-04-13 | MORYTKO TAMARA | Director | 171 | $27,829 | |
| 2026-04-13 | TUFANO PAUL J | Director | 268 | $43,593 | |
| 2026-04-13 | HABIGER DAVID C | Director | 171 | $27,829 | |
| 2026-03-27 | UPLINGER CHAD C | Officer | 18 | · | |
| 2026-03-27 | MATTHEWS MARK E | Chief Technology Officer | 18 | · | |
| 2026-03-27 | KNAUSENBERGER LAUREN | Director | 8 | · | |
| 2026-03-27 | FISHER KEITH D | Officer | 25 | · | |
| 2026-03-27 | FLUDDER STEVEN M. | Director | 31 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 8 May2026 | Ro Khanna | Democrat | buy | 1K–15K |
| 7 Oct2025 | Tommy Tuberville | Republican | sell | 15K–50K |
| 7 Oct2025 | Tommy Tuberville | Republican | sell | 15K–50K |
| 30 Mar2026 | Alan Armstrong | Republican | buy | 1K–15K |
| 29 Oct2024 | Tommy Tuberville | Republican | sell | 15K–50K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $236.82 | -6.3% | · | $937 | -6.3% |
| 2 months | $191.01 | +16.1% | · | $1,161 | +16.1% |
| 3 months | $159.49 | +39.1% | $0.26 | $1,392 | +39.2% |
| 6 months | $150.65 | +47.2% | $0.53 | $1,476 | +47.6% |
| 1 year | $88.88 | +149.6% | $1.03 | $2,507 | +150.7% |
| 2 years | $103.54 | +114.2% | $1.97 | $2,161 | +116.1% |
| 3 years | $101.29 | +119.0% | $2.82 | $2,218 | +121.8% |
| 5 years | $90.82 | +144.2% | $4.05 | $2,487 | +148.7% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever ENS does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.
